Occudo Quantitative Strategies LP Laboratory Corp Of America Holdings Transaction History

Occudo Quantitative Strategies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $386,136 - $439,703	1,822 New	1,822 $439,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $867,575 - $1.11 Million	-4,236 Reduced 47.35%	4,711 $965,000
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $618,055 - $803,044	2,890 Added 47.71%	8,947 $2.1 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $1.82 Million - $2.09 Million	-7,000 Reduced 53.61%	6,057 $1.6 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $177,354 - $205,179	653 Added 5.26%	13,057 $4.1 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $2.12 Million - $2.38 Million	7,723 Added 164.99%	12,404 $3.49 Million
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $1.18 Million - $1.3 Million	4,681 New	4,681 $1.29 Million
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $711,343 - $885,464	-3,472 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $648,951 - $744,466	3,472 New	3,472 $707,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.